About
Ansbert Gadicke, M.D., co-founded MPM in 1997 with his partner Luke Evnin. Over many years the MPM team they have led has been the inspiration and driving force behind building leading biopharmaceutical companies such as Biomarin (BMRN), CoStim Pharmaceuticals (acquired by Novartis:NVS), Epizyme (EPZM), Pacira (PCRX), Pharmasset (acquired by Gilead:GILD) and Radius (RDUS). MPM believes that these companies are some of the biggest successes in biotech history-companies that ultimately resulted in helping thousands of patients live longer and with vastly improved lives. Ansbert was the lead investor and has served on the boards of several of MPM’s most successful investments including BioMarin, Idenix, Pharmasset and Radius. Prior to the launching of MPM’s venture investing activities, Ansbert led MPM’s Advisory and Investment Banking business, and prior to that he was at The Boston Consulting Group in their Boston office in the Health Care Group. Ansbert was first to study expression
Position in the VCSift Database
- • 14 investors at MPM Capital are tracked.
- • 16 investors hold the Managing Director and Co-Founder role in VCSift. Ansbert Gadicke is one of them.
- • 491 investors are based in Cambridge, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Cambridge, US
Contact Information
Find more investors like Ansbert
Search Investors